Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The vitamin K controversy

M W Huysman1, P J Sauer

  • 1Department of Pediatrics, Sophia Children's Hospital, Rotterdam, The Netherlands.

Current Opinion in Pediatrics
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Newborns with vitamin K deficiency benefit from oral vitamin K, while maternal supplementation prevents early-onset disease. Intramuscular injections are debated due to potential cancer links, making oral administration a safer alternative.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analgesics, sedatives and neuromuscular blockers as part of end-of-life decisions in Dutch NICUs.

Archives of disease in childhood. Fetal and neonatal edition·2009
Same author

Physician end-of-life decision-making in newborns in a less developed health care setting: insight in considerations and implementation.

Acta paediatrica (Oslo, Norway : 1992)·2007
Same author

[Questionable basis for 'hopeless and unbearable suffering' as the criterion for the active termination of life in newborns with spina bifida].

Nederlands tijdschrift voor geneeskunde·2005
Same author

[Deliberate termination of life in newborns in The Netherlands; review of all 22 reported cases between 1997 and 2004].

Nederlands tijdschrift voor geneeskunde·2005
Same author

[Breast feeding during the first few days after birth: sometimes insufficient].

Nederlands tijdschrift voor geneeskunde·2003
Same author

Measurement of parameters of cholic acid kinetics in plasma using a microscale stable isotope dilution technique: application to rodents and humans.

Journal of lipid research·2001
Same journal

For health, for beauty, or both? navigating trends as adolescent clinicians.

Current opinion in pediatrics·2026
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
See all related articles

Area of Science:

  • Neonatal Medicine
  • Pediatric Hematology
  • Pharmacology

Background:

  • Recent discussions have reignited the debate on vitamin K prophylaxis efficacy and safety.
  • Hemorrhagic disease of the newborn (HDN) presents in early, classic, and late forms, necessitating effective preventive strategies.
  • Concerns exist regarding a potential association between intramuscular vitamin K and cancer, prompting a re-evaluation of administration routes.

Purpose of the Study:

  • To review advancements in diagnosing vitamin K deficiency, including plasma vitamin K levels and PIVKA-II detection.
  • To evaluate the efficacy of different vitamin K prophylaxis methods for preventing early, classic, and late HDN.
  • To critically assess the safety concerns surrounding intramuscular vitamin K administration and explore alternatives.

Main Methods:

Related Experiment Videos

  • Literature review focusing on diagnostic techniques for vitamin K deficiency.
  • Analysis of studies investigating the efficacy of oral versus intramuscular vitamin K for HDN prevention.
  • Examination of research on the potential link between vitamin K administration and cancer risk.

Main Results:

  • New diagnostic tools, such as vitamin K plasma levels and PIVKA-II detection, improve the diagnosis of vitamin K deficiency.
  • Oral vitamin K administration is effective in preventing classic and late HDN.
  • Maternal vitamin K supplementation is recommended for preventing early HDN, particularly in mothers using medications affecting vitamin K metabolism.

Conclusions:

  • Repeated oral administration of vitamin K is recommended for preventing classic and late HDN due to its safety profile.
  • Maternal vitamin K supplementation is a key strategy for preventing early HDN.
  • The potential risks associated with intramuscular injections warrant consideration, favoring oral routes for routine prophylaxis.